Compare JUBILANT LIFE SCIENCES with Divis Laboratories - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

JUBILANT LIFE SCIENCES vs DIVIS LABORATORIES - Comparison Results

DIVIS LABORATORIES 
   Change

Established in the year 1990, Divi's Laboratories has been focusing on CRAMS and is an established player in the custom chemical synthesis (CCS) and API/Intermediate segment. Around 50% of Divi's revenues are derived from custom manufacturing for glo... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    JUBILANT LIFE SCIENCES DIVIS LABORATORIES JUBILANT LIFE SCIENCES/
DIVIS LABORATORIES
 
P/E (TTM) x 13.4 34.3 39.0% View Chart
P/BV x 1.6 6.6 23.7% View Chart
Dividend Yield % 1.0 0.9 102.8%  

Financials

 JUBILANT LIFE SCIENCES   DIVIS LABORATORIES
EQUITY SHARE DATA
    JUBILANT LIFE SCIENCES
Mar-19
DIVIS LABORATORIES
Mar-19
JUBILANT LIFE SCIENCES/
DIVIS LABORATORIES
5-Yr Chart
Click to enlarge
High Rs8981,639 54.8%   
Low Rs6181,115 55.4%   
Sales per share (Unadj.) Rs572.0186.3 307.0%  
Earnings per share (Unadj.) Rs36.251.0 71.1%  
Cash flow per share (Unadj.) Rs59.557.3 103.8%  
Dividends per share (Unadj.) Rs4.5016.00 28.1%  
Dividend yield (eoy) %0.61.2 51.1%  
Book value per share (Unadj.) Rs301.9261.8 115.3%  
Shares outstanding (eoy) m159.28265.47 60.0%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x1.37.4 17.9%   
Avg P/E ratio x20.927.0 77.4%  
P/CF ratio (eoy) x12.724.0 53.0%  
Price / Book Value ratio x2.55.3 47.7%  
Dividend payout %12.431.4 39.6%   
Avg Mkt Cap Rs m120,694365,592 33.0%   
No. of employees `0002.411.8 20.2%   
Total wages/salary Rs m19,2605,423 355.2%   
Avg. sales/employee Rs Th38,120.64,175.1 913.0%   
Avg. wages/employee Rs Th8,058.4457.7 1,760.5%   
Avg. net profit/employee Rs Th2,414.31,141.8 211.4%   
INCOME DATA
Net Sales Rs m91,10849,463 184.2%  
Other income Rs m3571,556 23.0%   
Total revenues Rs m91,46651,019 179.3%   
Gross profit Rs m17,39018,718 92.9%  
Depreciation Rs m3,7091,689 219.6%   
Interest Rs m2,19835 6,280.3%   
Profit before tax Rs m11,84018,551 63.8%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m-2,8020-   
Tax Rs m3,2685,023 65.1%   
Profit after tax Rs m5,77013,527 42.7%  
Gross profit margin %19.137.8 50.4%  
Effective tax rate %27.627.1 101.9%   
Net profit margin %6.327.3 23.2%  
BALANCE SHEET DATA
Current assets Rs m45,84846,501 98.6%   
Current liabilities Rs m20,8978,468 246.8%   
Net working cap to sales %27.476.9 35.6%  
Current ratio x2.25.5 40.0%  
Inventory Days Days57131 43.4%  
Debtors Days Days5186 59.3%  
Net fixed assets Rs m65,49825,797 253.9%   
Share capital Rs m159531 30.0%   
"Free" reserves Rs m47,93068,962 69.5%   
Net worth Rs m48,08969,493 69.2%   
Long term debt Rs m42,4290-   
Total assets Rs m114,68580,383 142.7%  
Interest coverage x6.4531.0 1.2%   
Debt to equity ratio x0.90-  
Sales to assets ratio x0.80.6 129.1%   
Return on assets %6.916.9 41.2%  
Return on equity %12.019.5 61.6%  
Return on capital %12.426.7 46.4%  
Exports to sales %00-   
Imports to sales %024.6 0.0%   
Exports (fob) Rs mNANA-   
Imports (cif) Rs mNA12,187 0.0%   
Fx inflow Rs m12,42241,238 30.1%   
Fx outflow Rs m17,22712,405 138.9%   
Net fx Rs m-4,80528,833 -16.7%   
CASH FLOW
From Operations Rs m11,2159,543 117.5%  
From Investments Rs m-10,118-6,854 147.6%  
From Financial Activity Rs m6,574-2,459 -267.3%  
Net Cashflow Rs m7,612230 3,315.4%  

Share Holding

Indian Promoters % 45.6 52.0 87.7%  
Foreign collaborators % 3.5 0.0 -  
Indian inst/Mut Fund % 8.7 11.8 73.7%  
FIIs % 21.2 19.0 111.6%  
ADR/GDR % 0.0 0.0 -  
Free float % 21.1 17.2 122.7%  
Shareholders   23,815 31,796 74.9%  
Pledged promoter(s) holding % 15.9 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare JUBILANT LIFE SCIENCES With:   SHASUN PHARMA  DR. REDDYS LAB  GSK PHARMA  UNICHEM LAB  PROCTER & GAMBLE HEALTH  

Compare JUBILANT LIFE SCIENCES With:   MYLAN (US)  ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Sensex Ends above 39,000-Mark; Automobile and Banking Stocks Witness Buying(Closing)

Extending gains to the fifth day, Indian share markets rose sharply during the afternoon session and ended on a strong note.

Related Views on News

DIVIS LABORATORIES 2018-19 Annual Report Analysis (Annual Result Update)

Oct 10, 2019 | Updated on Oct 10, 2019

Here's an analysis of the annual report of DIVIS LABORATORIES for 2018-19. It includes a full income statement, balance sheet and cash flow analysis of DIVIS LABORATORIES. Also includes updates on the valuation of DIVIS LABORATORIES.

JUBILANT LIFE SCIENCES 2018-19 Annual Report Analysis (Annual Result Update)

Sep 5, 2019 | Updated on Sep 5, 2019

Here's an analysis of the annual report of JUBILANT LIFE SCIENCES for 2018-19. It includes a full income statement, balance sheet and cash flow analysis of JUBILANT LIFE SCIENCES. Also includes updates on the valuation of JUBILANT LIFE SCIENCES.

DIVIS LABORATORIES Announces Quarterly Results (1QFY20); Net Profit Up 0.4% (Quarterly Result Update)

Aug 13, 2019 | Updated on Aug 13, 2019

For the quarter ended June 2019, DIVIS LABORATORIES has posted a net profit of Rs 3 bn (up 0.4% YoY). Sales on the other hand came in at Rs 11 bn (up 14.5% YoY). Read on for a complete analysis of DIVIS LABORATORIES's quarterly results.

JUBILANT LIFE SCIENCES Announces Quarterly Results (1QFY20); Net Profit Down 7.7% (Quarterly Result Update)

Jul 29, 2019 | Updated on Jul 29, 2019

For the quarter ended June 2019, JUBILANT LIFE SCIENCES has posted a net profit of Rs 2 bn (down 7.7% YoY). Sales on the other hand came in at Rs 22 bn (up 5.0% YoY). Read on for a complete analysis of JUBILANT LIFE SCIENCES's quarterly results.

DIVIS LABORATORIES Announces Quarterly Results (4QFY19); Net Profit Up 10.6% (Quarterly Result Update)

May 27, 2019 | Updated on May 27, 2019

For the quarter ended March 2019, DIVIS LABORATORIES has posted a net profit of Rs 3 bn (up 10.6% YoY). Sales on the other hand came in at Rs 13 bn (up 15.5% YoY). Read on for a complete analysis of DIVIS LABORATORIES's quarterly results.

More Views on News

Most Popular

My 3 Best Small-cap Stocks to Get Rich in this Market Rebound(Profit Hunter)

Oct 14, 2019

This is once in a decade opportunity to make a killing from smallcap rebound.

Finally, Is the Share Price of Yes Bank Ready for a Rebound?(The 5 Minute Wrapup)

Oct 7, 2019

Here's what every individual investor must know about Yes Bank...

The One Stock I Like in this Market(The 5 Minute Wrapup)

Oct 10, 2019

There are rare periods in markets when you get good quality stocks at attractive valuations. Is this one such period?

Rebound Riches Could be Yours With These Stocks(Profit Hunter)

Oct 4, 2019

The secret to multibagger is not big businesses, but great managements... Here's how to find them to make the most of once in a decade rebound opportunity.

5 Smart Money Stocks to Profit from the Market Rebound(The 5 Minute Wrapup)

Oct 11, 2019

Now is the time to put money in these 5 stocks to take advantage of the recovery in the economy and the markets.

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2020
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

JUBILANT LIFE SCIENCES SHARE PRICE


Oct 17, 2019 03:37 PM

TRACK JUBILANT LIFE SCIENCES

  • Track your investment in JUBILANT LIFE SCIENCES with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON JUBILANT LIFE SCIENCES

JUBILANT LIFE SCIENCES 5-YR ANALYSIS

COMPARE JUBILANT LIFE SCIENCES WITH

MARKET STATS